Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Visionstate Announces Deals in Canada and the US, Highlights Growing Opportunities (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Revive Therapeutics Ltd C.RVV

Alternate Symbol(s):  RVVTF

Healthcare Biotechnology
Revive Therapeutics Ltd. is a Canada-based life sciences company. The Company is focused on the research and development of therapeutics and diagnostics for infectious diseases, medical countermeasures, and rare disorders. It is engaged in exploring the use of Bucillamine for the potential treatment of nerve agent exposure and long COVID. The Company, through its diagnostics division, is evaluating a point-of-care in vitro diagnostic device that aids in the detection of post COVID-19 conditions or Long COVID. It also advancing the development of Psilocybin-based therapeutics through various programs. The Company's subsidiaries include Revive Therapeutics Inc. (Ontario), Revive Diagnostics Inc., and Psilocin Pharma Corp. (Ontario).


CSE:RVV - Post by User

Revive Therapeutics Ltd > Great read, reasons why the Phase 3 trial will be a success.
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(3)
•••
Comment by cool888on Sep 15, 2021 8:19pm
115 Views
Post# 33866623

RE:RE:RE:RE:RE:Great read, reasons why the Phase 3 trial will be a success.

RE:RE:RE:RE:RE:Great read, reasons why the Phase 3 trial will be a success.
Dmfb12 wrote:

You're right, Cool posts a lot of pointless, mind numbing posts, but every once and awhile he posts something with merit

if ur gonna give the guy a hard time, atleast do it on a post that's stupid. This one was really good, the Reddit user explained everything and provided links to what he was saying. Did you even open the link? I can promise it's not a paid promoter this time


no need to pointless bash anyone on this forum, enjoy the content and take what u will from it 




Thanks Dmfb12. Nice to know, there ARE few good Men/Women in the world !! GLTA

Enjoy the evening folks .... Great Days Ahead !!

https://www.youtube.com/watch?v=PgCliOxl41o&ab_channel=Yohani



<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities